SON-1010

N/A

Report date: 2026/02/04 20:00:52

Base Information

Drug NameSON-1010
Drug Alias NameIL12-FHABSON-1010
ClassificationBiologics > Protein drugs > Recombinant protein > Fusion protein
Mechanisms of ActionInterleukin-12 receptor inhibitors
TargetsInterleukin-12 receptor
Therapy Area/IndicationsSolid tumoursFallopian Tube NeoplasmsPeritoneal Neoplasms +[5
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesAustralia
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesSonnet Biotherapeutics Inc
China Registration ClassN/A

Develop Information

Inactive CompaniesN/A
Active IndicationsSarcoma
Inactive IndicationsSolid tumoursFallopian Tube NeoplasmsPeritoneal Neoplasms +[4

Other Information

ATC CodeN/A
Related LinksN/A